Monograph Title | Section | Source Publication | Page Number | Errata Post Date Sort ascending | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
MAFENIDE ACETATE FOR TOPICAL SOLUTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 16-Dec-2022 | 1-Jan-2023 | NA | NA | In System suitability: Change Samples: System suitability solution, Standard solution A, and Standard solution B to: Samples: System suitability solution and Standard solution A AND … Read More |
LYSINE HYDROCHLORIDE | IMPURITIES/Related Compounds | USPNF Online | Online | 16-Dec-2022 | 1-Jun-2023 | NA | NA | In Chromatographic system/Spray reagent: Change 0.2 g of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) to: 2 mg/mL of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) |
PALONOSETRON HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 16-Dec-2022 | 1-Jan-2023 | NA | NA | In Limit of Unspecified Impurities: Change Mobile phase and Chromatographic system: Proceed as directed in the Assay. to: Mobile phase, Standard stock solution, and Chromatographic system: Proceed… Read More |
ROCURONIUM BROMIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | USPNF 2023 Issue 3 | In footnote b of Table 1: Change 2β-(Morpholin-4-yl)-16β-(pyrrolidin-1-yl)-5α-androstan-3α,17β-diol. to: 2β-(Morpholin-4-yl)-16β-(pyrrolidin-1-yl)-5α-androstane-3α,17β-diol. |
CHLORHEXIDINE GLUCONATE ORAL RINSE | IMPURITIES/Limit of p-Chloroaniline | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change Standard solution: 1.0 µg/mL of USP p-Chloroaniline RS in Diluent to: Standard solution: 0.001 mg/mL of USP p-Chloroaniline RS in Diluent AND In Analysis: Change Result = (rU… Read More |
MOMETASONE FUROATE TOPICAL SOLUTION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In test A: Change The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, both relative to the internal standard, as obtained in the Assay. to: The retention time of the major… Read More |
FELODIPINE | IMPURITIES/Organic Impurities | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change Buffer, Mobile phase, System suitability solution, Standard solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay. to: Buffer, Mobile phase… Read More |
PENICILLIN G BENZATHINE INJECTABLE SUSPENSION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change It responds to the Identification test under Penicillin G Benzathine Oral Suspension. to: Mix a portion of it with methanol to obtain a solution containing about 3000 Penicillin G Units per mL. Apply 20 µL of this test solution and… Read More |
ADIPIC ACID | IMPURITIES/Related Substances | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Table 2: Change Pimelic acid 1.21 0.91 Valeric acid 1.21 0.91 to: Pimelic acid 1.21 0.91 Valeric acid 1.46 0.88 |
ROCURONIUM BROMIDE | CHEMICAL INFORMATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | USPNF 2023 Issue 3 | Change 609.68 to: 609.69 |
ZINC UNDECYLENATE | ASSAY/Procedure | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Solution A: Change 0.15 N hydrochloric acid in water prepared as follows. Transfer 150 mL of hydrochloric acid to a 500-mL volumetric flask, dilute with water to volume, and mix well. to: 0.15 N hydrochloric acid in water prepared as follows.… Read More |
PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE INJECTABLE SUSPENSION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Test A: Change It responds to the Identification test under Penicillin G Benzathine Oral Suspension: the spot obtained from the test solution, corresponding in RF value to that obtained from the Standard solution, is… Read More |
POTASSIUM CITRATE EXTENDED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Test 6: Change Times: 0.5, 1, and 4 h—for strengths 540 and 1080 mg as potassium citrate monohydrate; 0.5, 1, and 6 h—for strength 1620 mg as potassium citrate monohydrate. to: Times: 0.5, 1, and 4 h—for strength 540 mg as potassium… Read More |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IMPURITIES/Related Compounds | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change CS = concentration of USP Calcium DL-5-Methyltetrahydrofolate RS in the Standard solution (mg/mL) to: CS = concentration of USP Calcium D,L-5-Methyltetrahydrofolate RS in the … Read More |
SITAGLIPTIN PHOSPHATE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change 523.32 to: 523.33 AND Change (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate to: (3R)-3-Amino-1-[3-(trifluoromethyl)-… Read More |
DOFETILIDE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change β-[(p-Methanesulfonamidophenethyl)methylamino]methane sulfono-p-phenetidide to: N-{4-[2-(Methyl{2-[4-(methylsulfonamido)phenoxy]ethyl}amino)ethyl]phenyl}methanesulfonamide |
CALCIUM UNDECYLENATE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Solution A: Change 0.15 N hydrochloric acid in water prepared as follows. Transfer 150 mL of hydrochloric acid to a 500-mL volumetric flask, dilute with water to volume, and mix well. to: 0.15 N hydrochloric acid in water prepared as follows.… Read More |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IDENTIFICATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In A. Spectroscopic Identification Tests <197>, Infrared Spectroscopy: 197K: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
TETRACYCLINE HYDROCHLORIDE | SPECIFIC TESTS/Bacterial Endotoxins Test <85> | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change Where the label states tetracycline hydrochloride must be subjected to further processing during the preparation of injectable dosage forms, the level of bacterial endotoxins are such that the requirement under the relevant dosage form monograph(s) in… Read More |
DOXORUBICIN HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DIAZOXIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In footnote a in Table 2: Change 7-Chloro-2H-benzothiadiazin-3(4H)-one 1,1-dioxide. to: 7-Chloro-2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxide. |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IMPURITIES/Enantiomeric Purity | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Standard solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
PRIMIDONE TABLETS | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Sample solution: Change 0.05 mg/mL of primidone from the Standard stock solution in Diluent to: 0.05 mg/mL of primidone from the Sample stock solution in Diluent |
ANETHOLE | DEFINITION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change (E)-1-methyl-4-(1-propenyl) benzene to: (E)-1-methoxy-4-(1-propenyl) benzene |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In System suitability solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS AND In Standard solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-… Read More |
TETRACYCLINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/Labeling | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change Where tetracycline hydrochloride must be sterile or subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled. to: Where Tetracycline Hydrochloride must be… Read More |
DOXORUBICIN HYDROCHLORIDE INJECTION | IMPURITIES/Organic Impurities | USPNF 2022 Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DOXAZOSIN MESYLATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change CS = concentration of the corresponding USP Doxazosin Related Compound RS or USP Doxazosin Mesylate RS (for calculating unspecified impurities) in the Standard solution (mg/mL) to: CS… Read More |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
ENZACAMENE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Analysis: Change CU = concentration of enzacamene in the Sample solution (mg/mL) to: CU = concentration of Enzacamene in the Sample solution (mg/mL) |
NALOXONE HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Limit of Naloxone Related Compound D: Delete Sensitivity solution: 1.25 µg/mL of USP Naloxone Related Compound D RS in 0.1 N hydrochloric acid AND In System suitability/Samples: Delete Sensitivity solution,… Read More |
N-Benzoyl-L-arginine Ethyl Ester Hydrochloride | REAGENT SPECIFICATIONS | USPNF Online | Online | 30-Sep-2022 | 1-Dec-2022 | NA | NA | Change Crystallized Trypsin (USP Monograph). to: Trypsin (USP Monograph). |
SODIUM PICOSULFATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Buffer: Change cetylrimethylammonium bromide, to: cetyltrimethylammonium bromide, |
LANSOPRAZOLE DELAYED-RELEASE CAPSULES | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | Delete Blank: Methanol and Diluent (1:9) |
TERAZOSIN CAPSULES | ASSAY/Procedure | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Hydrochloric acid solution: Change 0.1 N methanolic hydrochloric acid to: 0.01 N methanolic hydrochloric acid |
CEFTIOFUR HYDROCHLORIDE | ASSAY/Procedure | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Analysis: Change Calculate the percentage of ceftiofur (C19H17N5O7S3) in the portion of Ceftiofur Hydrochloride taken: Result = (rU/rS… Read More |
POTASSIUM GLUCONATE | IMPURITIES/Reducing Substances | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In Titrimetric system: Change Titrant: Iodine Back-titrant: Sodium thiosulfate to: Titrant: 0.1 N Iodine VS Back-titrant: 0.1 N Sodium Thiosulfate VS |
0.1 N Potassium Permanganate VS | STANDARDIZATION | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In Standardization with potentiometric endpoint: Change N = g Na2C2O4/mL KMNnO4 solution × 0.06700 to: N = g Na2C2O4/mL KMnO4 solution × 0.06700 |
DACARBAZINE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In System suitability/Suitability requirements/Signal-to-noise ratio: Change NTL 10, to: NLT 10, |
PROMETHAZINE HYDROCHLORIDE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change System suitability solution: 5 µg/mL each of USP Promethazine Hydrochloride RS and USP Promethazine Related Compound B RS from the Standard stock solution and System suitability stock solution, respectively Standard… Read More |
METHYLENE BLUE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Azure B RS: Change 3-(Dimethylamino)-7-(methylamino)-phenothiazine-5-ium chloride. to: 3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride. |
METHSUXIMIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In System suitability/Column efficiency: Change NTL 5800 theoretical plates to: NLT 5800 theoretical plates |
PROCHLORPERAZINE MALEATE TABLETS | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In Analysis: Change Results = (AU/AS) × CS × D × (1/L) × V × 100 AU = absorbance of the Sample solution AS = absorbance… Read More |
<467> RESIDUAL SOLVENTS | USP REFERENCE STANDARDS <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change USP Residual Solvent Class 2—Mixture C RS to: USP Residual Solvents Class 2—Mixture C RS |
IRINOTECAN HYDROCHLORIDE INJECTION | DEFINITION | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change NTL 90.0% and NMT 110.0% to: NLT 90.0% and NMT 110.0% |
0.1 M ZINC SULFATE VS | STANDARDIZATION | USPNF Online | Online | 26-Aug-2022 | 1-Dec-2022 | NA | NA | In Standardization with visual end point: Change M = mL edetate disodium × edetate disodium/mL ZnSO4 to: M = mL edetate disodium × M edetate disodium/mL ZnSO4 AND In Standardization with potentiometric end point… Read More |
ECONAZOLE NITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Econazole Related Compound C RS: Change 1-(4-Chlorobenzyl)-3-{2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazol-3-ium nitrate (salt). C25H21Cl14N3O4 569.… Read More |
<621> CHROMATOGRAPHY | ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS | USPNF Online | Online | 26-Aug-2022 | 1-Dec-2022 | NA | NA | In Liquid Chromatography: Isocratic Elution/Injection volume: Change L2 = internal diameter of the column used (mm) dc1 = particle size indicated in the monograph (µm) dc2 =… Read More |